ArticleAmerican journal of translational research2022
Effectiveness and safety of retrograde intrarenal surgery (RIRS) vs. percutaneous nephrolithotomy (PCNL) in the treatment of isolated kidney stones.
Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.
- Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis of stone-free rates and complication profiles.International urology and nephrology · 2026Pooled it
- Longer-term effects of intraoperative cone-beam computed tomography in percutaneous nephrolithotomy: 18-month retrospective randomised controlled trial analysis.BJU international · 2025Trial
- Retrograde intra renal surgery (RIRS) versus percutaneous nephrolithotomy (PNL) as a primary treatment for large renal stones: A prospective randomized controlled trial.Arab journal of urology · 2026Article
- Comparison of flexible ureteroscopy with flexible and navigable suction ureteral access sheath and mini-percutaneous nephrolithotripsy for the treatment of impacted upper ureteral stones: a retrospective study.Frontiers in surgery · 2025Article
- Percutaneous nephrolithotomy or flexible ureteral lithotripsy, which one is better for patients with upper ureteral calculi of 1.5-2.0 cm in diameter.BMC urology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the effectiveness and safety of retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL) in the treatment of isolated kidney stones.
methodsA retrospective analysis was performed on 99 patients with isolated kidney stones treated in our hospital. Patients were divided into a flexible cystoscope group (FCG, n=48, receiving RIRS) and a nephoscopy group (NG, n=51, receiving PCNL) according to the operation methods. The two groups were compared in terms of the operative time, intraoperative bleeding, length of hospitalization, time to bowel function recovery, cost of hospitalization, one-session stone clearance, postoperative incidence of massive hemorrhage, postoperative 1-year recurrence rate, and levels of hemoglobin, urinary kidney injury molecule-1 (Kim-1), cysteine protease inhibitor C (Cys-C), interleukin (IL)-6, IL-10, cortisol (Cor), white blood cells (WBC) and C-reactive protein (CRP).
resultsThe two groups exhibited significant differences in operation time, intraoperative bleeding, hospital stay, time to bowel function recovery and medical costs (
conclusionBoth RIRS and PCNL were effective in the treatment of isolated kidney stones, so the surgical methods should be specifically selected in clinical practice according to individual patient conditions.
Indexed as
Identifiers
35422937PMC8991168W4226158607What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.